Japan AGM Voting Results & Director Approval
Annual meeting voting results, director support and shareholder dissent.
Data through · Updated with new filings
0
board nominees with under 80% support at 2026 meetings
The lowest was Rohto Pharmaceutical's nominee at 89.42%.
1 row matches “4527” · Clear · Go to Rohto Pharmaceutical (4527) →
Lowest director approval
11 meeting · 14 board nominees, each meeting's lowest approval first
The line marks 80% approval.
| Director | Proposal | Approval | Result | Filing |
|---|---|---|---|---|
| 山田 邦雄+13 other nominees, 91.48%–99.22%Rohto Pharmaceutical4527 · ロート製薬 | Election of 14 directorsOriginal (Japanese)取締役14名選任の件 | 89.42%Votes cast: 89.68% · For 1,781,901 / Against 199,559 / Abstain 5,500 | Approved | Filed — filing S100YLZB |
Rejected proposals
8| Company | Proposal | Approval | Result | Filing |
|---|---|---|---|---|
| Rohto Pharmaceutical4527 · ロート製薬 | Dismissal of 1 director(s)Machine translatedOriginal (Japanese)取締役1名解任の件 | 11.20%†Votes cast: 11.20% · For 222,456 / Against 1,763,689 / Abstain 825 | Rejected | Filed — filing S100YLZB |
| Rohto Pharmaceutical4527 · ロート製薬 | Amendment of the articles of incorporation regarding the establishment of a Strategy Review CommitteeMachine translatedOriginal (Japanese)戦略検討委員会の設置に関する定款変更の件 | 8.98%†Votes cast: 8.98% · For 178,453 / Against 1,807,701 / Abstain 825 | Rejected | Filed — filing S100YLZB |
| Rohto Pharmaceutical4527 · ロート製薬 | Amendment of the Articles of Incorporation regarding the decision-making body for dividends of surplus, etc.Machine translatedOriginal (Japanese)剰余金の配当等の決定機関に関する定款変更の件 | 48.17%†Votes cast: 48.17% · For 957,061 / Against 1,029,092 / Abstain 825 | Rejected | Filed — filing S100YLZB |
| Rohto Pharmaceutical4527 · ロート製薬 | Matter of repurchase of the company's own sharesMachine translatedOriginal (Japanese)自己株式取得の件 | 11.14%†Votes cast: 11.14% · For 221,346 / Against 1,764,807 / Abstain 825 | Rejected | Filed — filing S100YLZB |
| Rohto Pharmaceutical4527 · ロート製薬 | Approval of the remuneration amount under the restricted stock compensation systemMachine translatedOriginal (Japanese)譲渡制限付株式報酬制度に関する報酬額承認の件 | 17.40%†Votes cast: 17.40% · For 345,736 / Against 1,640,381 / Abstain 825 | Rejected | Filed — filing S100YLZB |
| Rohto Pharmaceutical4527 · ロート製薬 | Amendment of the articles of incorporation regarding the composition of outside directorsMachine translatedOriginal (Japanese)社外取締役の構成に関する定款変更の件 | 15.01%†Votes cast: 15.01% · For 298,246 / Against 1,686,969 / Abstain 1,741 | Rejected | Filed — filing S100YLZB |
| Rohto Pharmaceutical4527 · ロート製薬 | Amendment of the Articles of Incorporation regarding measures toward realizing management that takes into account the cost of capital and share priceMachine translatedOriginal (Japanese)資本コストや株価を意識した経営の実現に向けた対応に関する定款変更の件 | 13.56%†Votes cast: 13.56% · For 269,449 / Against 1,716,684 / Abstain 825 | Rejected | Filed — filing S100YLZB |
| Rohto Pharmaceutical4527 · ロート製薬 | Matter regarding amendment of the Articles of Incorporation concerning the record date of the annual general meeting of shareholdersMachine translatedOriginal (Japanese)定時株主総会の基準日に関する定款変更の件 | 9.45%†Votes cast: 9.45% · For 187,808 / Against 1,798,343 / Abstain 825 | Rejected | Filed — filing S100YLZB |
Shareholder proposals ≥ 20%
1| Company | Proposal | Approval | Result | Filing |
|---|---|---|---|---|
| Rohto Pharmaceutical4527 · ロート製薬 | Amendment of the Articles of Incorporation regarding the decision-making body for dividends of surplus, etc.Machine translatedOriginal (Japanese)剰余金の配当等の決定機関に関する定款変更の件 | 48.17%†Votes cast: 48.17% · For 957,061 / Against 1,029,092 / Abstain 825 | Rejected | Filed — filing S100YLZB |
Approval is the ratio the company states (usually of the voting rights of shareholders present); votes cast are for ÷ (for + against + abstain).
† Percentage of votes cast; company did not state a ratio.
† Company-stated ratio differs from tallied votes.
Related tools
Tender offers
Tender offer prices, windows, conditions and disclosed outcomes.
Activist & 5% stakes
Disclosed stakes above 5%, with activist groups and ownership changes.